0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-8M10299
Home | Market Reports | Health| Health Conditions
Global Small Intestinal Bacterial Overgrowth SIBO Diagnostics Market Insights Forecast to 2028
BUY CHAPTERS

Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-8M10299
Report
October 2024
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics - Market

Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics - Market

Small intestinal bacterial overgrowth (SIBO) is commonly seen in the presence of one or more predisposing conditions. It varies highly based on the underlying disorders and microbiota characteristics of patients and organisms. SIBO results in gastrointestinal IBS-like symptoms, which could be asymptomatic. In worse cases, it may result in real malabsorption syndrome. The presence of SIBO is generally diagnosed with hydrogen lactulose and glucose breath tests. These tests are widely performed in every clinical setting due to their low costs, non-invasively, sufficient accuracy, and reproducibility.
The global market for Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics by region & country, by Type, and by Application.
The Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics.
Market Segmentation

Scope of Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics - Market Report

Report Metric Details
Report Name Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics - Market
CAGR 5%
Segment by Type:
  • Hydrogen-predominant SIBO
  • Methane-predominant SIBO
  • Recurrent SIBO
Segment by Application
  • Hospitals
  • Physician Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Genova Diagnostics, SIBO Diagnostics, Commonwealth Diagnostics International, Aerodiagnostics, LLC, SIBOTest, Metabolic Solutions, Inc., Pivotal Diagnostics, DirectLabs, LLC, Vibrant Wellness, Health Associates Medical Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics - Market report?

Ans: The main players in the Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics - Market are Genova Diagnostics, SIBO Diagnostics, Commonwealth Diagnostics International, Aerodiagnostics, LLC, SIBOTest, Metabolic Solutions, Inc., Pivotal Diagnostics, DirectLabs, LLC, Vibrant Wellness, Health Associates Medical Group

What are the Application segmentation covered in the Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics - Market report?

Ans: The Applications covered in the Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics - Market report are Hospitals, Physician Clinics, Others

What are the Type segmentation covered in the Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics - Market report?

Ans: The Types covered in the Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics - Market report are Hydrogen-predominant SIBO, Methane-predominant SIBO, Recurrent SIBO

Recommended Reports

Diagnostics & Testing

Gastrointestinal Market

In Vitro Diagnostics

1 Market Overview
1.1 Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Product Introduction
1.2 Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Size Forecast
1.3 Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Trends & Drivers
1.3.1 Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Industry Trends
1.3.2 Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Drivers & Opportunity
1.3.3 Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Challenges
1.3.4 Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Players Revenue Ranking (2023)
2.2 Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Revenue by Company (2019-2024)
2.3 Key Companies Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Product Offered
2.5 Key Companies Time to Begin Mass Production of Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics
2.6 Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Competitive Analysis
2.6.1 Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Hydrogen-predominant SIBO
3.1.2 Methane-predominant SIBO
3.1.3 Recurrent SIBO
3.2 Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Type
3.2.1 Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value, by Type (2019-2030)
3.2.3 Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Physician Clinics
4.1.3 Others
4.2 Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Application
4.2.1 Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value, by Application (2019-2030)
4.2.3 Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Region
5.1.1 Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Region (2019-2024)
5.1.3 Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Region (2025-2030)
5.1.4 Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value, 2019-2030
5.2.2 North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value, 2019-2030
5.3.2 Europe Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value, 2019-2030
5.4.2 Asia Pacific Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value, 2019-2030
5.5.2 South America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value, 2019-2030
5.6.2 Middle East & Africa Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value
6.3 United States
6.3.1 United States Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value, 2019-2030
6.3.2 United States Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value, 2019-2030
6.4.2 Europe Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value, 2019-2030
6.5.2 China Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value, 2019-2030
6.6.2 Japan Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value, 2019-2030
6.7.2 South Korea Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value, 2019-2030
6.8.2 Southeast Asia Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value, 2019-2030
6.9.2 India Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Genova Diagnostics
7.1.1 Genova Diagnostics Profile
7.1.2 Genova Diagnostics Main Business
7.1.3 Genova Diagnostics Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Products, Services and Solutions
7.1.4 Genova Diagnostics Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Revenue (US$ Million) & (2019-2024)
7.1.5 Genova Diagnostics Recent Developments
7.2 SIBO Diagnostics
7.2.1 SIBO Diagnostics Profile
7.2.2 SIBO Diagnostics Main Business
7.2.3 SIBO Diagnostics Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Products, Services and Solutions
7.2.4 SIBO Diagnostics Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Revenue (US$ Million) & (2019-2024)
7.2.5 SIBO Diagnostics Recent Developments
7.3 Commonwealth Diagnostics International
7.3.1 Commonwealth Diagnostics International Profile
7.3.2 Commonwealth Diagnostics International Main Business
7.3.3 Commonwealth Diagnostics International Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Products, Services and Solutions
7.3.4 Commonwealth Diagnostics International Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Revenue (US$ Million) & (2019-2024)
7.3.5 Aerodiagnostics, LLC Recent Developments
7.4 Aerodiagnostics, LLC
7.4.1 Aerodiagnostics, LLC Profile
7.4.2 Aerodiagnostics, LLC Main Business
7.4.3 Aerodiagnostics, LLC Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Products, Services and Solutions
7.4.4 Aerodiagnostics, LLC Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Revenue (US$ Million) & (2019-2024)
7.4.5 Aerodiagnostics, LLC Recent Developments
7.5 SIBOTest
7.5.1 SIBOTest Profile
7.5.2 SIBOTest Main Business
7.5.3 SIBOTest Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Products, Services and Solutions
7.5.4 SIBOTest Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Revenue (US$ Million) & (2019-2024)
7.5.5 SIBOTest Recent Developments
7.6 Metabolic Solutions, Inc.
7.6.1 Metabolic Solutions, Inc. Profile
7.6.2 Metabolic Solutions, Inc. Main Business
7.6.3 Metabolic Solutions, Inc. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Products, Services and Solutions
7.6.4 Metabolic Solutions, Inc. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Revenue (US$ Million) & (2019-2024)
7.6.5 Metabolic Solutions, Inc. Recent Developments
7.7 Pivotal Diagnostics
7.7.1 Pivotal Diagnostics Profile
7.7.2 Pivotal Diagnostics Main Business
7.7.3 Pivotal Diagnostics Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Products, Services and Solutions
7.7.4 Pivotal Diagnostics Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Revenue (US$ Million) & (2019-2024)
7.7.5 Pivotal Diagnostics Recent Developments
7.8 DirectLabs, LLC
7.8.1 DirectLabs, LLC Profile
7.8.2 DirectLabs, LLC Main Business
7.8.3 DirectLabs, LLC Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Products, Services and Solutions
7.8.4 DirectLabs, LLC Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Revenue (US$ Million) & (2019-2024)
7.8.5 DirectLabs, LLC Recent Developments
7.9 Vibrant Wellness
7.9.1 Vibrant Wellness Profile
7.9.2 Vibrant Wellness Main Business
7.9.3 Vibrant Wellness Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Products, Services and Solutions
7.9.4 Vibrant Wellness Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Revenue (US$ Million) & (2019-2024)
7.9.5 Vibrant Wellness Recent Developments
7.10 Health Associates Medical Group
7.10.1 Health Associates Medical Group Profile
7.10.2 Health Associates Medical Group Main Business
7.10.3 Health Associates Medical Group Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Products, Services and Solutions
7.10.4 Health Associates Medical Group Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Revenue (US$ Million) & (2019-2024)
7.10.5 Health Associates Medical Group Recent Developments
8 Industry Chain Analysis
8.1 Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Industrial Chain
8.2 Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Model
8.5.2 Sales Channel
8.5.3 Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Trends
    Table 2. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Drivers & Opportunity
    Table 3. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Challenges
    Table 4. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Restraints
    Table 5. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Product Type
    Table 9. Key Companies Time to Begin Mass Production of Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics
    Table 10. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Region (2019-2024) & (%)
    Table 27. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value, (2025-2030) & (US$ Million)
    Table 31. Genova Diagnostics Basic Information List
    Table 32. Genova Diagnostics Description and Business Overview
    Table 33. Genova Diagnostics Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Business of Genova Diagnostics (2019-2024)
    Table 35. Genova Diagnostics Recent Developments
    Table 36. SIBO Diagnostics Basic Information List
    Table 37. SIBO Diagnostics Description and Business Overview
    Table 38. SIBO Diagnostics Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Business of SIBO Diagnostics (2019-2024)
    Table 40. SIBO Diagnostics Recent Developments
    Table 41. Commonwealth Diagnostics International Basic Information List
    Table 42. Commonwealth Diagnostics International Description and Business Overview
    Table 43. Commonwealth Diagnostics International Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Business of Commonwealth Diagnostics International (2019-2024)
    Table 45. Commonwealth Diagnostics International Recent Developments
    Table 46. Aerodiagnostics, LLC Basic Information List
    Table 47. Aerodiagnostics, LLC Description and Business Overview
    Table 48. Aerodiagnostics, LLC Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Business of Aerodiagnostics, LLC (2019-2024)
    Table 50. Aerodiagnostics, LLC Recent Developments
    Table 51. SIBOTest Basic Information List
    Table 52. SIBOTest Description and Business Overview
    Table 53. SIBOTest Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Business of SIBOTest (2019-2024)
    Table 55. SIBOTest Recent Developments
    Table 56. Metabolic Solutions, Inc. Basic Information List
    Table 57. Metabolic Solutions, Inc. Description and Business Overview
    Table 58. Metabolic Solutions, Inc. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Business of Metabolic Solutions, Inc. (2019-2024)
    Table 60. Metabolic Solutions, Inc. Recent Developments
    Table 61. Pivotal Diagnostics Basic Information List
    Table 62. Pivotal Diagnostics Description and Business Overview
    Table 63. Pivotal Diagnostics Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Business of Pivotal Diagnostics (2019-2024)
    Table 65. Pivotal Diagnostics Recent Developments
    Table 66. DirectLabs, LLC Basic Information List
    Table 67. DirectLabs, LLC Description and Business Overview
    Table 68. DirectLabs, LLC Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Business of DirectLabs, LLC (2019-2024)
    Table 70. DirectLabs, LLC Recent Developments
    Table 71. Vibrant Wellness Basic Information List
    Table 72. Vibrant Wellness Description and Business Overview
    Table 73. Vibrant Wellness Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Business of Vibrant Wellness (2019-2024)
    Table 75. Vibrant Wellness Recent Developments
    Table 76. Health Associates Medical Group Basic Information List
    Table 77. Health Associates Medical Group Description and Business Overview
    Table 78. Health Associates Medical Group Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Business of Health Associates Medical Group (2019-2024)
    Table 80. Health Associates Medical Group Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Downstream Customers
    Table 84. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Product Picture
    Figure 2. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 4. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Report Years Considered
    Figure 5. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Revenue in 2023
    Figure 7. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Hydrogen-predominant SIBO Picture
    Figure 9. Methane-predominant SIBO Picture
    Figure 10. Recurrent SIBO Picture
    Figure 11. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Hospitals
    Figure 14. Product Picture of Physician Clinics
    Figure 15. Product Picture of Others
    Figure 16. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value (%), (2019-2030)
    Figure 29. United States Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 50. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Industrial Chain
    Figure 51. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0I20198
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33W11115
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart